Panobinostat potentiates the cytotoxic effects of ara-C and daunorubicin on acute myeloid leukemia cells through suppressing the DNA damage response

被引：0
作者：
Xie, Chengzhi [1 ]
Edwards, Holly [1 ]
Drenberg, Christina [2 ]
Baker, Sharyn D. [2 ]
Inaba, Hiroto [2 ]
Buck, Steven A. [3 ]
Taub, Jeffrey W. [3 ]
Ge, Yubin [1 ]
机构：
[1] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[2] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[3] Childrens Hosp Michigan, Detroit, MI 48201 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2739
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2739
引用
收藏
页数：2
相关论文
共 50 条
[1]   LONG-TERM RESULTS IN ACUTE MYELOID-LEUKEMIA TREATED WITH CONVENTIONAL DAUNORUBICIN, ARA-C (DA) AND THIOGUANINE, ARA-C, DAUNORUBICIN (TAD) POLYCHEMOTHERAPY [J].
FREUND, M ;
LINK, H ;
BODENSTEIN, H ;
POLIWODA, H .
BLUT, 1986, 53 (03) :241-241
[2]   Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage [J].
Xie, Chengzhi ;
Edwards, Holly ;
Caldwell, J. Timothy ;
Wang, Guan ;
Taub, Jeffrey W. ;
Ge, Yubin .
MOLECULAR ONCOLOGY, 2015, 9 (02) :409-421
[3]   DAE (DAUNORUBICIN, ARA-C, AND ETOPOSIDE) AND INTERMEDIATE DOSE ARA-C FOR REMISSION INDUCTION AND CONSOLIDATION TREATMENT OF ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA [J].
HWANG, WL ;
YOUNG, JH ;
GAU, JP ;
HU, HT ;
TSAI, YT .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (06) :531-534
[4]   Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia [J].
Richard L Momparler .
Experimental Hematology & Oncology, 2 (1)
[5]   Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia [J].
Momparler, Richard L. .
EXPERIMENTAL HEMATOLGY & ONCOLOGY, 2013, 2
[6]   VARIATION IN SENSITIVITY OF DNA-SYNTHESIS TO ARA-C IN ACUTE MYELOID-LEUKEMIA [J].
HARRIS, AL ;
GRAHAMESMITH, DG .
BRITISH JOURNAL OF HAEMATOLOGY, 1980, 45 (03) :371-379
[7]   Topoisomerase IIα expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-C [J].
Tina, Elisabet ;
Prenkert, Malin ;
Hoglund, Martin ;
Paul, Christer ;
Tidefelt, Ulf .
ONCOLOGY REPORTS, 2009, 22 (06) :1527-1531
[8]   THE RELATIONSHIP OF ARA-C METABOLISM INVITRO TO THERAPEUTIC RESPONSE IN ACUTE MYELOID-LEUKEMIA [J].
HARRIS, AL ;
GRAHAMESMITH, DG .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (01) :30-35
[9]   SMALL DOSES OF ARA-C IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA - DIFFERENTIATION OF MYELOID-LEUKEMIA CELLS [J].
HOUSSET, M ;
DANIEL, MT ;
DEGOS, L .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (01) :125-129
[10]   Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML) [J].
Erba, H. P. ;
Rizzieri, D. A. ;
O'Donnell, M. R. ;
Lundberg, A. S. ;
Ajami, A. M. ;
Rampersad, A. D. ;
Capizzi, R. L. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345